Long Covid remains a major concern for millions worldwide. After an infection caused by the SARS-CoV-2 virus, many ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

Three children were rescued from a COVID lockdown house of horrors after being forced for years to stay inside and wear face ...

With over 65 million people suffering globally, US scientists have begun a major clinical trial to test a monoclonal antibody ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal ...

Everything we know about a horrifying case where parents in Spain allegedly kept their children indoors for four years due to ...

The explanation for this treatment involves the cholinergic nervous system. The German scientists point out that SARS-CoV-2 ...

The economic burden of long COVID may exceed $2 billion and reach nearly $31 billion when symptoms last between 1 and 3 years, and researchers say these numbers will likely continue to grow as ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Four related studies sought to examine overlooked impacts of long COVID — when symptoms of the infection last at least three months — on children and young adults. Young people typically have ...

The following is a summary of “A biopsychosocial analysis of risk factors for persistent physical, cognitive, and ...